Status
Conditions
About
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.
A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
Full description
To close the gap of missing clinical evidence regarding the treatment of periprosthetic fractures after arthroplasty of the hip or the knee with osteosynthesis.
To drive further study hypotheses and to answer unforeseen questions.
Main questions to be answered by the registry include (but are not exclusive) the following:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥18 years
Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
Informed consent obtained, i.e.:
Ability to attend post-operative follow up visits
Exclusion criteria
Loading...
Central trial contact
Viola Grünenfelder; Marco Minoia
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal